acuteadditionadenocarcinomaadjuvantadolescentsadultsadvancedalkamlamonganalysisannualanotherarticleascoassessmentassociatedautologousbasedbetterbevacizumabbiologybiomarkerbiopsybladderbrafbrainbrca1breastcancercancerscarcinomacardiaccarecellchemoradiationchemotherapychildhoodchildrencllcoloncolorectalcombinationdatadecisiondetectiondiagnoseddiffusediscussiondiseasedisparitiesdondosedurvalumabearlyefficacyegfrendendometrialevolutionfinancialfirstfollicularfollowfollowinggastricgermlinehealthhematopoieticher2highhodgkinhormonehoursiiiimagingimmuneimpactimplicationsimportanceimproveimprovesinducedinhibitioninhibitorinsightsinvasivelargelateleukemialifelikelinelocallylonglowlunglymphoblasticlymphomalymphomasmaintenancemanagementmedicalmedicaremeetingmelanomametastasesmetastaticminimalmolecularmortalitymrdmultimultiplemutantmutationmutationsmyeloidmyelomanegativeneoadjuvantnivolumabnovelnsclcolderoptionsoutcomeoutcomesovarianpancreaticpatientpatientspediatricpembrolizumabphasepluspositiveprimaryprimeprognosticpromiseprostatequalityquestionracialradiationradiotherapyrarereadyreceivingreceptorrectalrecurrencerecurrentrefractoryrelapsedrelatedresearchresidualresponseresultsriskrituximabrolesafetyscreeningsecondsettingsinglesmallsmokingstagestemstudysurgerysurvivalsurvivorssystemsystemictermtestingtherapeutictherapytimetoxicitytransplanttransplantationtrastuzumabtreatedtreatmenttrialtrialstumortumorsuseusingvalueversuswomenyoung